Oncology Pharma Inc.
ONPH
$0.0001
$0.000.00%
OTC PK
| 12/31/2004 | 09/30/2004 | 06/30/2004 | 03/31/2004 | 12/31/2003 | |
|---|---|---|---|---|---|
| Revenue | 94.00K | 233.00K | 654.00K | 1.18M | 2.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.00K | 233.00K | 654.00K | 1.18M | 2.00M |
| Cost of Revenue | 29.00K | 183.00K | 420.00K | 654.00K | 954.00K |
| Gross Profit | 65.00K | 50.00K | 234.00K | 527.00K | 1.05M |
| SG&A Expenses | 577.00K | 906.00K | 1.40M | 1.85M | 1.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 679.00K | 1.27M | 2.10M | 2.88M | 3.41M |
| Operating Income | -585.00K | -1.03M | -1.45M | -1.70M | -1.40M |
| Income Before Tax | -507.00K | -954.00K | -1.37M | -1.57M | -1.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.51 | -0.95 | -1.37 | -1.57 | -1.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -507.00K | -954.00K | -1.37M | -1.57M | -1.52M |
| EBIT | -585.00K | -1.03M | -1.45M | -1.70M | -1.40M |
| EBITDA | -512.30K | -958.50K | -1.37M | -1.62M | -1.25M |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |